Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × thymoglobulin × Clear all

NCT00995059 2023-01-05

Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma

Phase 1/2 Withdrawn

Multiple Myeloma